芎冰喷雾剂治疗急性缺血性中风的实验与临床研究
|
摘要
目的：
通过实验与临床研究,阐明芎冰喷雾剂对急性缺血性脑卒中的疗效及其作用机理,通过芎冰普通制剂与纳米制剂的药效对比,予纳米制剂客观评价,并为芎冰喷雾剂的推广应用提供科学的理论和实践依据。
方法：
(一)实验研究：采用线栓法制作大鼠大脑中动脉缺血再灌注损伤模型,并采用神经功能评分、TTC染色、实时荧光定量-PCR、HE染色后光镜下观察显微结构及检测血清中炎症因子等方法,分别对假手术组、缺血再灌注组(模型组)、尼莫通组、普通芎冰喷雾剂、芎冰纳米喷雾剂(高、低剂量)组的缺血后大鼠神经功能缺失征象、再灌注后缺血侧脑梗塞体积,Caspase-3. AQP4基因表达的定量,TNF-α、IL-1β的含量进行观测和比较。
(二)临床研究：按照随机对照原则,将60例急性缺血性脑卒中患者分为治疗组(常规西药加用芎冰喷雾剂)和常规西药对照组,疗程均为两周,重点观察治疗前后患者的中医证候评分、神经功能缺损程度评分。
结果：
(一)实验研究：普通制剂组、尼莫通组、纳米制剂高剂组均能明显改善脑缺血大鼠的神经功能缺损程度,减少缺血体积,下调Caspase-3、AQP4基因的表达,减轻缺血缺氧缺血的病理改变,有效抑制TNF-α、IL-1β的升高,其中三种制剂的疗效大致相似,而部分指标则提示普通芎冰喷雾剂、芎冰纳米制剂高剂量的效果更优于尼莫通。
(二)临床研究：治疗组中医证候积分及神经功能缺损程度积分明显优于对照组,但中医证候疗效与对照组尚无统计学差别。安全性研究证明芎冰纳米喷雾剂无明显肝肾毒性及严重不良反应。
结论：
芎冰喷雾剂通过抗细胞凋亡,减轻缺血后脑水肿,抑制炎症反应等而发挥对抗缺血再灌注损伤的作用,具有显著的脑保护作用,纳米制剂有其优越之处,但仍有待改进。临床观察表明芎冰喷雾剂能改善急性缺血性中风患者神经功能缺损症状,是治疗急性缺血性脑卒中的理想药物之一,值得推广应用。
Objective:To investigate the effect and mechanism of Xiongbing spray in treating acute cerebral ischemic stroke by experimental and clinical study, objective evaluate the effect of nanometer praeparatum by comparing to the common praeparatum, and provide the bases for using Xiongbing spray in clinical practice.
Method:
Animal experimental study:seventy-eight SD rats were randomly divided into six groups:the pseudo operated group, the model group (operated), Nimoldipine group, Common praeparatum group, and nanometer praeparatum groups (treated with high and low dose respective). The rats cerebral ischemic stroke model were subjected to focal ischemic by middle cerebral artery occlusion(MCAO)using intraluminal thread. The neurologic impairment scoring, cerebral ischemic area measured by TTC-staining, the quantity of gene expression by Caspase-3 and AQP4 in ischemic brain tissue, the result of pathology photograph, and the level of TNF-αand IL-1βin the peripheral blood were observed and compared between groups.
clinical study:sixty patients were randomly divided into therapy group (treated with Xiongbing spray and general westen medicine) and controlled group(only using general westen medicine), the treatment period was two weeks. The neurologic impairment scoring, clinical effect of TCM syndrome were observed before and after treatment, as well as the security of Xiongbing spray.
Result:
Animal experimental study:Common praeparatum, nanometer praeparatum with high dose and nimoldipine could ameliorate the scorings of neural deficit of cerebral ischemic stroke rats, reduce cerebral ischemic area measured by TTC-staining, decrease quantity of gene expression by Caspase-3 and AQP4 in ischemic brain tissue, active suppress the increase of TNF-αand IL-1βin the peripheral blood, significant reductions of nerval tissue damage were also found in the three groups by pathology photograph. Experimental result show that therapeutic effect of three kinds of praeparatum above-mentioned is similar on the whole, while part of it manifest common praeparatum and high dose nanometer praeparatum surpass nimoldipine.
clinical study:the ameliorations of the scoring of neural deficit in Xiongbing spray group were predominant compared with controlled group, the same case could be seen in the scoring of TCM syndrome while curative effect of TCM syndrome without statistics difference between groups. The function of liver and renal, blood general measuring were normal before and after treatment,there was no severe adverse reactions in patients caused by Xiongbing spray.
Conclusions:
Xiongbing spray has remarkable protective effect against focal brain damage induced by occlusion-reperfusion, which can inhibiting neural cells apotosis, reduce ischemic brain edema and controling Inflammatory reaction. nanometer praeparatum has its own predominance although need to improve. Xiongbing spray could ameliorate the scorings of neural deficit in patients, We can conclude that Xiongbing spray be one of ideal medicines for acute cerebral ischemic stroke.
通过实验与临床研究,阐明芎冰喷雾剂对急性缺血性脑卒中的疗效及其作用机理,通过芎冰普通制剂与纳米制剂的药效对比,予纳米制剂客观评价,并为芎冰喷雾剂的推广应用提供科学的理论和实践依据。
方法：
(一)实验研究：采用线栓法制作大鼠大脑中动脉缺血再灌注损伤模型,并采用神经功能评分、TTC染色、实时荧光定量-PCR、HE染色后光镜下观察显微结构及检测血清中炎症因子等方法,分别对假手术组、缺血再灌注组(模型组)、尼莫通组、普通芎冰喷雾剂、芎冰纳米喷雾剂(高、低剂量)组的缺血后大鼠神经功能缺失征象、再灌注后缺血侧脑梗塞体积,Caspase-3. AQP4基因表达的定量,TNF-α、IL-1β的含量进行观测和比较。
(二)临床研究：按照随机对照原则,将60例急性缺血性脑卒中患者分为治疗组(常规西药加用芎冰喷雾剂)和常规西药对照组,疗程均为两周,重点观察治疗前后患者的中医证候评分、神经功能缺损程度评分。
结果：
(一)实验研究：普通制剂组、尼莫通组、纳米制剂高剂组均能明显改善脑缺血大鼠的神经功能缺损程度,减少缺血体积,下调Caspase-3、AQP4基因的表达,减轻缺血缺氧缺血的病理改变,有效抑制TNF-α、IL-1β的升高,其中三种制剂的疗效大致相似,而部分指标则提示普通芎冰喷雾剂、芎冰纳米制剂高剂量的效果更优于尼莫通。
(二)临床研究：治疗组中医证候积分及神经功能缺损程度积分明显优于对照组,但中医证候疗效与对照组尚无统计学差别。安全性研究证明芎冰纳米喷雾剂无明显肝肾毒性及严重不良反应。
结论：
芎冰喷雾剂通过抗细胞凋亡,减轻缺血后脑水肿,抑制炎症反应等而发挥对抗缺血再灌注损伤的作用,具有显著的脑保护作用,纳米制剂有其优越之处,但仍有待改进。临床观察表明芎冰喷雾剂能改善急性缺血性中风患者神经功能缺损症状,是治疗急性缺血性脑卒中的理想药物之一,值得推广应用。
Objective:To investigate the effect and mechanism of Xiongbing spray in treating acute cerebral ischemic stroke by experimental and clinical study, objective evaluate the effect of nanometer praeparatum by comparing to the common praeparatum, and provide the bases for using Xiongbing spray in clinical practice.
Method:
Animal experimental study:seventy-eight SD rats were randomly divided into six groups:the pseudo operated group, the model group (operated), Nimoldipine group, Common praeparatum group, and nanometer praeparatum groups (treated with high and low dose respective). The rats cerebral ischemic stroke model were subjected to focal ischemic by middle cerebral artery occlusion(MCAO)using intraluminal thread. The neurologic impairment scoring, cerebral ischemic area measured by TTC-staining, the quantity of gene expression by Caspase-3 and AQP4 in ischemic brain tissue, the result of pathology photograph, and the level of TNF-αand IL-1βin the peripheral blood were observed and compared between groups.
clinical study:sixty patients were randomly divided into therapy group (treated with Xiongbing spray and general westen medicine) and controlled group(only using general westen medicine), the treatment period was two weeks. The neurologic impairment scoring, clinical effect of TCM syndrome were observed before and after treatment, as well as the security of Xiongbing spray.
Result:
Animal experimental study:Common praeparatum, nanometer praeparatum with high dose and nimoldipine could ameliorate the scorings of neural deficit of cerebral ischemic stroke rats, reduce cerebral ischemic area measured by TTC-staining, decrease quantity of gene expression by Caspase-3 and AQP4 in ischemic brain tissue, active suppress the increase of TNF-αand IL-1βin the peripheral blood, significant reductions of nerval tissue damage were also found in the three groups by pathology photograph. Experimental result show that therapeutic effect of three kinds of praeparatum above-mentioned is similar on the whole, while part of it manifest common praeparatum and high dose nanometer praeparatum surpass nimoldipine.
clinical study:the ameliorations of the scoring of neural deficit in Xiongbing spray group were predominant compared with controlled group, the same case could be seen in the scoring of TCM syndrome while curative effect of TCM syndrome without statistics difference between groups. The function of liver and renal, blood general measuring were normal before and after treatment,there was no severe adverse reactions in patients caused by Xiongbing spray.
Conclusions:
Xiongbing spray has remarkable protective effect against focal brain damage induced by occlusion-reperfusion, which can inhibiting neural cells apotosis, reduce ischemic brain edema and controling Inflammatory reaction. nanometer praeparatum has its own predominance although need to improve. Xiongbing spray could ameliorate the scorings of neural deficit in patients, We can conclude that Xiongbing spray be one of ideal medicines for acute cerebral ischemic stroke.
引文
[1]李澎涛,王永炎,黄启福.“毒损脑络”病机假说的形成及其理论与实践意义[J].北京中医药大学学报,2001,24(1)：1-6.
[2]王新陆.脑血辨证[M],北京：中国医药科技出版社,2002：82-99.
[3]丁元庆.卢尚岭调气为主治疗急性中风经验[J].山东中医药大学学报,2000,24(1)：43-44.
[4]赵海滨,马东信,沈承玲.邵念方“中风无风论”初探[J].中国中医急症,2001,10(1)：40-41.
[5]张宏伟,刘东霞.张学文中医世家经验辑要[M].西安：陕西科学技术出版社,2004：79-82.
[6]王辉,刘金榜.陶根鱼主任医师治疗中风后遗症经验总结[J].国医论坛,2007,22(2)：13-14.
[7]李奎生.试论活血化瘀法在中风治疗中的地位[J].医药世界,2007,11(2)：103-104.
[8]孙丽红.中风血瘀致病说文献探微[J].上海中医药杂志,2007,41(11)：68-70.
[9]张国平,刘华,别晓东.不同类型中风血瘀证患者血液流变学和凝血谱指标的研究[J].全科医学临床与教育,2006,4(3)：204-210.
[10]藏燕坤.活血化瘀法治疗出血性脑卒中急性期50例[J].河南中医,2007,17(9)：36.
[11]周鲁,张庆,宋航,等.治疗中风的复方用药规律研究[J].辽宁中医杂志,2007,34(1)：8-9
[12]唐映红,邓常青,刘旺华,等.补阳还五汤4类有效部位对局灶性脑缺血大鼠脑梗死体积的影响[J].中草药,2005,36(2)：236.
[13]王新高,童萼塘,孙圣刚.补阳还五汤对大鼠脑缺血再灌注损伤后血脑屏障的影响[J].中国动脉硬化杂志,2005,13(5)：579.
[14]彭康,孙忠.补阳还五汤对中风后遗症“气虚血瘀”大鼠脑组织三磷酸腺苷及二磷酸腺苷和单胺类神经递质的影响[J].中国临床康复,2004,8(10)：1908.
[15]张淑萍,梁燕,邓常青.补阳还五汤及其有效部位对大鼠脑缺血再灌注后Caspase表达的影响[J].中草药,2006,37(7)：1041.
[16]刘柏炎,蔡光先,林琳,等.补阳还五汤对大鼠局灶性脑缺血后神经干细胞影响的初步研究[J].中国临床康复,2004,8(22)：4532.
[17]高兴来.通腑泻下法在中风病中的运用[J].实用中医内科杂志,2008,22(9)：68-69.
[18]王永炎.化痰通腑法治疗缺血性中风158例疗效观察[J].中国医药学报
,1986,1(2)：22.
[19]李凤玲.化痰通腑汤灌肠治疗中风病急性期痰热腑实证158例[J].中医杂志,2008,49(7)：637.
[20]王永炎.中医内科学[M].上海：上海科学技术出版社,1997,124-132.
[21]赵孔华,张园.缺血性脑中风的发病机理探讨[J].河南中医,2006,26(7)：7.
[22]祝美珍.缺血性中风病证本质的客观化研究与探讨[J].中西医结合心脑血管病杂志,2006,4(9)：775.
[23]张佛明,张新春,黄燕.痰瘀同治法治疗缺血性中风Meta分析[J].南京中医药大学学报,2007,23(6)：358-361.
[24]麻志恒.化瘀祛痰汤治疗脑梗塞的临床疗效观察[J].中成药,2009,31(2)：177-179.
[25]胡怀强,周永红,王新陆.试论滋补肝肾是促进中枢神经再生的重要方法[J].天津中医药,2009,26(4)：296-298.
[26]许宏霞,曹晓岚.肾虚与中风后抑郁发病的关系浅析[J].中西医结合心脑血管病杂志,2007,5(8)：725-726.
[27]张俊平,武荣芳,王丽,等.补肾益气活血法与缺血性中风[J].中国中医急症,2008,17(2)：193-194.
[28]邓启玉.补肾活血法为主治疗缺血性中风恢复期80例[J].实用中医药杂志,2008,24(1)：16-17.
[29]李家邦,李瑛,熊国良,等.肝阳化风证病理生理学基础的进一步研究[J].湖南医科大学学报,2000,25(4)：3.
[30]陈孝银,肖蒲鲜,范隆昌.肝阳上亢者部分免疫指标变化的检测分析[J].四川中医,2000,18(3)：7.
[31]赵继伟.缺血性中风急性期中医治疗体会[J].中西医结合心脑血管病杂志,2004,2(2)：119.
[32]李炯侠.自拟平肝熄风汤治疗急性缺血性中风30例[J].陕西中医,2008,29(2)：168-169.
[33]刘晓俊,高敏,黄汉超,等.调肝治法干预中风后抑郁症患者对汉密尔顿抑郁量表及血浆皮质醇水平的影响[J].现代中西医结合杂志,2008,17(7)：3101-3102.
[34]韩凤芹,王亚利,邢继军.潜阳熄风胶囊治疗中风病先兆证85例临床观察[J].辽宁中医杂志,2008,35(10)：1508-1509.
[35]常富业,王永炎.中风病毒邪论[J].北京中医药大学学报,2004,27(1)：3-6.
[36]吴子辉,吴林,毒为出血性中风至笃之本[J].广西中医药,2005,28(1)：49-50.
[37]许宏霞,曹晓岚,王敏.对缺血性中风病急性期炎症反应的中西医认识[J].中西医结 合心脑血管病杂志,2007,5(2)：155-157.
[38]黄宇虹,张伯礼.中风病发病时中医证候特点浅析[J].天津中医药大学学报,2007,26(2)：59-60.
[39]张占军,李澎,王忠.精制清开灵干预MCAO再灌注损伤的药效及机制研究[J].中国病理生理杂志,2006,22(11)：2105-2109.
[40]沈强,刘亚敏,张赐安,等.麝香、冰片对全脑缺血再灌注大鼠脑微血管内皮细胞ICAM-1表达的影响[J].中西医结合心脑血管病杂志,2003,1(3)：36.
[41]李小球,刘煜德,梁云花.开窍法对骨髓基质干细胞颈动脉内移植治疗缺血性中风的增效作用[J].中国中医急症,2008,17(6)：804-805.
[42]方永奇,魏刚,吴启端,等.石菖蒲醒脑开窍作用物质基础及其作用机制研究[J].医学研究杂志,2007,36(9)：60.
[43]钮跃贞.鼻腔给药的研究概况[J].中国新药与临床杂志,2001,20(5)：381-383.
[44]杨开清,李荣,陈宏珪.脑醒喷鼻剂治疗急性缺血性中风66例[J].广州中医药大学学报,2003,20(1)：28-30.
[45]李荣,吴伟,陈宏硅.不同剂量脑醒喷鼻剂对再灌注损伤脑组织自由基及一氧化氮合酶变化的干预[J].中国临床康复,2005,9(21)：254-256.
[46]李荣,吴伟,刘煜德,等.脑醒喷鼻剂对脑缺血再灌注损伤抗炎保护作用的实验研究[J].新中医,2005,35(8)：93-94.
[47]Danton G H, Dietrich W D. Inflammatory mechanisms after ischemia and stroke [J]. Neuropathol ExpNeurol,2003,62:127-37.
[48]Hess D C,Howard E, Cheng C, et al.Hypcrtonic mannitol loading of NF-κB transcription factor decoys in human brain microvascular endothdial cells blocks upregulation of ICAM-1[J]. Stroke,2000,31:1179-86.
[49]Gibson C L, Jones NC, Prior MJ, et al. G-CSF suppresses edema formation and reduces interleukin-1 beta expression after cerebral ischemia in mice[J]. Neuropathol Exp Neurol,2005,64(9):763.
[50]Zhans J T, Wu W P, Zhans FY. Interleukin-1 β Converting Enzyme Gene Expression after Cerebral Ischemia Repefusion[J]. J Mil Med,2002,27:56-58.
[51]Bin X, Liu X W, Liu X W. Interleukir-1 Chansing in Cerebral Cortex and Hippocampi after all Brain Ischemia Reperfusion[J].Clin Recovery,2002,6: 50-51.
[52]Auan S M, Parker L C, CO lins B. Cortical Cel Death Induced by IL-1 is Mediated Via Actions in the Hypothalamus of the Rat[J]. Proc Natl Acad Sci USA, 2000,97:5580-5581.
[53]Hillhouse E W, Kida S, lannoui F. Middle cerebral artery occlusion in the rat causes a biphasec production of immunoreactive interleukin-1 β the erebral cortex[J]. Neurosci Let,1998,249(23):177-179.
[54]Fabian R H, Perez-Polo JR, Kent TA. Electrochemical monitoring of supeorxide anion production and cerebral blood flow:effect of interleukin-1 β pretreatment in a model of focal ischemia and reperfusion[J]. J Neurosci Res,2000,60 (6):795-803.
[55]All C, Nicole O, Docagne F, et al. Ischemia-induced interleukin-6 as a potential indogenous neuroprotective cytokine against NMDA receptor mediated exitotoxicity in the brain[J].J Cereb Blood Plow Metab,2000,20(6):956-966.
[56]Suzuki S, Tanaka K, Nogawa S, et al. Expression of interleukin-6 is suppressed by inhibition of voltage sensitive Na+/Ca2+ channels after cerebral ischemia [J]. Neuroreport,2000,11(11):2565-2569.
[57]Loddick S H, Tumbull A V, Rothwell N J, et al. Cerebral interleukin-6 is neuro protective during permanent focal cerebual ischemia in the rat[J].J Cereb Blood Flow Metab,1998,18(2):176-179.
[58]Vilan, Castillo J, Davalos A, et al. Proinflammatory cytokines and early neurological worsening in ischemic stroke [J]. Stroke,2000,31(10):2325-2329.
[59]Zarembra J. Contribution of tumbor necrosis factor alpha to the pathogensis of stroke [J]. Folia Morphol(Warsz),2000,59(3):137-143.
[60]Yamasaki Y,ItoyamaY,Kogure K.Involvement of cytokine porductionin pathogenesis of transient cerebral ischemic damage[J]. Keio J Med,1996,45 (3):225-229.
[61]Wang CX, Shuaib A. Involvement of inflammatory cytokines incentral nervous system injury[J]. Pros Neurobiol,2002,67:161
[62]Abillerira S, Montaner J, Molina CA, et al. Matrix metalloproteinase-9 pretreatment level predictsin-tracranial hemorrhagic complications after thrombolysis in human stroke [J]. Circulation,2003,107:598-600.
[63]Chen L, Vicaut E, Sercombe RI. Polymorphonuclear leukocyte activation induces cerebral hypo-perfuslon in rats in the absence of previous ischemia-repefusion damage [J]. Neurosci Lett,2002,331:2037
[64]项洁,沈霞,耿德勤.肿瘤坏死因子-α在大鼠脑缺血再灌注中的表达及对神经细胞凋亡的影响[J].中国临床康复,2004,8(28)：6094-6095
[65]Botchkina GL, Geimonen E, Bilof ML, et al. Loss of NF Kappa B activity during cerebral ischemia and TNF cytotoxicity[J].Mol Med,2002,5(6):372-381.
[66]Zhai Q H, Fruell N, Chen F J, et al. Gene expression of IL-10 in relationship to TNF-alpha,IL-1 beta and IL-2 in the rat brain following middle cerebral artery occlusion[J]. J Newrol Sci,2003,152(2):119-124
[67]Barone FC, Arvin B, White RF, et al. Tumor necrosis factor-α:amediator of focal ischemic brain injury[J]. Stroke,2003,28(6):2733.
[68]Uno H, Matsuyama T, AkitaH, et al. Induction of tumor necrosis factor-α in the mouse hippocampus following transient forerbrain ischemia[J]. Cereb Blood Flow Metab,2004,17(5):49.
[69]Konemoto Y, Nakase H, Akita N, Sakald J.Elects of anti-inter-celular adhesion molecule-1 antibody on reperfusion iniury included by late reperfusion in the rat middle cerebral artery occlusion model [J]. Neurosygery, 2002,51:1034-1042
[70]夏斌,邵福源.CD11/CD18在脑缺血／再灌注损伤中的作用[J].国外医学,脑血管疾病分册,2000,8(3)：133.
[71]Zhang R L, Chopp M, Jiang N, et al. Anti-intercellular adhesion molecule-1 antibody reduces ischemic cell damage after transient but not permanent middle cerebral artery occlusion in the wistar rat [J]. Stroke,2002,26(8):1438-1447.
[72]Frijus C J, Kappelle L J. Inflammatory cell adhesion molecules ischemic cerebrovascular disease[J]. Stroke,2002,33(8):2115-2122.
[73]Berti R, Williams A J, Mofet J R, et al. Quantitative real-time RT-PCR analysis of inflammatory gene expression associated with ischemia-reperfusion brain injury[J].J Cereb Blood Flow Metab,2002,22(9):1068-1079.
[74]Zhang R, Chopp M, Zhang Z, et al. The expression of P-selectins and E-selectins in three models of middle cerebral artery occlusion[J]. Brain Research,2002,785(2):207-214.
[75]Haring H, Berg E L, Tsurushita N, et al. E-selectin appears in nonischemic tissue during experimental focal cerebral ischemia [J]. Stroke,2003,27(8): 1386-1392.
[76]Lee S R, Lo E H. Induction of caspase-mediated cell death by matrix metallo proteinases in cerebral endothelial cells after hypoxia-reoxygenafion[J]. J Cereb Blood Flow Metab,2004,24:720-727.
[77]Magnoni S, Baker A, George SJ. Diferenfial alterationsinthe expression and activity of matrix metallopmteinases 2 and 9 after transient cerbral ischemia in mice[J].Neurobiol Dis,2004,17:188.
[78]Shimakura A, Kamanaka Y, Ikeda Y,et al.Neutrophil elastase inhibition reduces cerebral ischemic damage in the middle cerebral artery occlusion[J]. Brain Res,2000,858:55-60.
[79]Tonai T, Shiba K, Taketani Y, et al. A neutrophil elastase inhibitor reduces neurologic damage after spinal cord injury in rats[J]. Neurothem,2001,78: 1064-1072.
[80]Bai W T, Chen LJ, Expression of platelet activating factor receptor gene during focal reversible ischemia of rat brain[J]. Stroke and Nervous Diseases,2005,12:2.
[81]Park TS, Gonzales ER, Giay JM. Platelet-activating factor mediates ischemia included leukocyte-endothelial adherence in new born pig brain[J]. Comb Blood Flow Metab,1999,19:417-424.
[82]Takai Y, Kishimoto A, Inoue M, et al. Studies on acyclic neurotide independent protein kinase and its proenzyme in mammalisan tissue[J]. Biol Chem,2001,252(61):7603.
[83]Nakayama R, Yano T, Ushijima K, et al. Effects of dantrolene on extracellular glutamate concentration and neuronal death in the rat hippocampal CAI region subjected to transient ischemia[J]. Anesthesiology, 2002,96(3):705-710.
[84]Nishizawa Y. Glutamate release and neuronal damage in ischemia[J]. Life Sci,2001,69:369-381.
[85]Dawso V L, Dawson TM, Batley DA, et al. Mechanism of nitric oxide-mediated neurotoxity in primary brain cultures[J]. J Neurosic,2003,13(6):2651-2661.
[86]Radi R, Backman J S, Bush K M, et al. Peroxynitite-induced membrane lipid peroxidation:the cytotoxic potential of superoxide and nitric oxide [J]. Arch Biochem Biophy,2001,288:481-487.
[87]Me Donald LJ, Moss J. Stimulation by nitric oxide of an NAD linkage to glyceraldehydes-3-phosphate dehydrogenase[J]. Proc NatlAcad Sci USA,2000,90: 6238-6241.
[88]Kontos H A. Oxygen radicals in cerebral ischemia:the 2001 Willis lecture [J]. Stroke,2001,32:2712-2716.
[89]Bates B,Hirt L,Thomas SS,et al. Neurotorphin-3 promotes cell death induced in cerebral ischemia,oxygen-glucose deprivation, and oxidative stress:possible involvement of oxygen free redicals[J]. Neuorbiol Dis,2002, 9(1):24-37.
[90]Kokubo Y, Matson GB, Liu J, et al. Correlation between changes in apparent difusion efficient and induction of heat shock protein, cell-specific injury marker experssion, and protein synthesis reduction on diffusion-weighted magnetic resonance images after temporary focal cerebral ischemia in rats[J]. J Neurosurg,2002,96(6):1084-1093.
[91]Ma RH, Wang YJ, Qu H, et al. Assessment of the early efectiveness of a stroke unit in comparison to the general ward[J]. Chin Med J,2004,117:852-855
[92]Liu XF, Fawcett JR, Thome RG, et al. Non-invasive intranasal insulin-like growth factor-Ⅰ reduces infarct volume and improve sneurologic function in rats following middle cerebral artery occlusion [J]. Neuro sci Lett,2001,308: 91-94.
[93]Yenari MA, Iwayama S, Cheng D, et al. Mild hypothermia attenuates eytochromec release but does not alter Bcl-2 expression or caspase activation after experimental stroke[J].J Cereb Blood Flow Metab,2002,22:29.
[94]Mrsic Pelcic J, Pelcic G, Vitezic D. Hyperbaric oxygen treatment:the influence on the hippocampal superoxide dismutase and Na+-K+-ATPase activities in global cerebral ischemia-exposed rats[J]. Neurochem lnt,2004,44:585.
[95]Li Y, Zhou C, Calvert J W, et al. Multiple efects of HBO on HIF-la expression and apoptotie genes in global ischemia rat model[J]. Neurol,2005,191:198.
[96]Lou M, Eschenfelder CC, Herdegen T, et al. Therapeutic window for use of hyperbaric oxygenation in focal transient ischemia in rats[J]. Stroke,2004, 35:578.
[97]张立群,陈洁丽,程众,等.尼莫地平对局灶性脑缺血.鼠脑血浆蛋白的影响[J].中风与神经疾病杂志,2001,18：300.
[98]Avshalumov M V, Rice ME. NMDA receptor activation mediates hydrogen peroxide-induced pathophysiology in rat hippocampal slices[J]. J Neurophysiol ,2002,87(6):2896-2903.
[99]Zalish M, Lavie V. Dexanabinol (HU 211) has a beneficial effect on axonal sprouting and survival after rat optic nerve crush injury [J]. Vision Res,2003, 43(3):237-242.
[100]Croxford J L.Therapeutic potential of cannabinoids in CNS disease [J]. CNS Drugs,2003,17(3):179-202.
[101]Kawasaki-Yatsugi S. Neuroprotective effects of an AMPA receptor antagonist YM872 in a rat transient middle cerebral artery occlusion mode[J]. Neuropharmacology,2000,39(2):211-217
[102]DeSarro G. Comparative anticonvulsant activity of some 2,3 benzodiaze pinederivative sinrodents[J]. Pharmacol Biochem Behav,2003,74(3):595-602
[103]毛春.镁对缺血性脑损伤的神经保护作用[J].国外医学：脑血管病分册,2000,8(10)：33.
[104]Lin J Y Chung S Y, Lin M C, et al. Efects of magnesium sulfate of energy metabolites and glutamate in the cortex during focal cerebral ischemia and reperfusion in the gerbil monitored by a dural-probe micro dia lysis technique[J]. Life Sci,2002,71(7):803-811.
[105]Kinoshita Y,Ueyama T, Senba E, et al. Expression of c-fos, heat shock protein 70, neurotropins, and cyclooxygenase-2 mRNA in response to focal cerebral ischemia/reperfusion in rats and their modification by magnesium sulfate[J]. J Neurotrauma,2001,18(4):435-445
[106]Lees K R. Does neuroprotection improve stroke outcome? [J]. Lancet,1998, 351(9114):1447-1448.
[107]潘家枯,张磊.脑梗死的药物治疗[J].中国新药与临床杂志,1999,18(4)：234.
[108]Diener H C, Hacke W, Hennerici M, et al. Lubeluzole in acute ischemic stroke:a double-blind placebo controlled phase II trail[J]. Stroke,1996,27: 76-81
[109]栗秀初,孟锦立.第16届世界神经科大会中有关缺血性中风的某些诊疗新观点和新措施简介.中风与神经疾病杂志,1998,15(2)：125-128.
[110]Leker R R, Neufeld M Y. Anti-epileptic drugs as possible neuroprotectantss in cerebral ischaemia[J]. Brain ResRev,2003,42(3):187-203.
[111]Wahlgrren N G, Pharmacological treatment of acute stroke [J]. Cerebralvasc Dis,1997,7(Suppl3):24-30.
[112]冯涛,王拥军,朱克.糖皮质激素受体阻断剂抑制成年雄性大鼠持续性局灶脑缺血后Caspase-3基因表达[J].卒中与神经疾病杂志,2004,11：208-212.
[113]Wu T W, Zeng L H, W u J,Fung KP.MCI-186:further histochemical and biochemical evidence of neuorprotection[J]. Life Sci,2002,67(19):2387-2393
[114]陈静宜.一种改善脑卒中病残性药物——依达拉奉[J].中国临床药学杂志,2002,11(4)：244-245.
[115]Bemeur Cste Marie L, Desjardins P, et al. Expression of superoxide dismutase in hyperlycemia focal cerebral ischemia in the rat[J]. Neurnohem lnt,2004:1167-1174.
[116]Danielisova V, Nemethova M, Burda J. The protective effect of aminoguanidineon cerebral ischemic damage in the rat brain[J]. Physiol Res,2004,53:533-540.
[117]李建军,孙琦,曹辉,等.神经节苷脂对大鼠脑缺血再灌注损伤的脑保护作用[J].临床神经病学杂志,2006,19：124-126.
[118]祝伟华,勾振堂,齐立伟,等.雌激索对大鼠脑缺血再灌注损伤脑皮质EAA含量的影响[J].中风与神经疾病杂志,2003,20：231-232.
[119]Regan M H. The effect of topical insulin on the release of excit otoxican do the raminoacids from the rat cerebral cortex during strepto-otocin induced hyperglycemic ischemia[J]. Brain Res,2000,872(1/2):29-36.
[120]Belayev L, liu Y, et al. Human albumin therapy of acute ischemic stroke:marked neuroprotective efficacy at moderate doses and with a broad therapeutic window[J]. Stroke,2001,32(2):553-560.
[121]Chest,2008,133 (6 Suppl):630-669.
[122]田凤石,张秀泉.老年急性缺血性心脑血管病患者血小板表面糖蛋白受体GPIIb/GPIlla的动态变化[J].中国危重病急救医学,2000,10(5)：304-305.
[123]Abciximab Emergent Stroke Treatment Trial(AbESTT) Investigators. Emergency administration of abciximab for treatment of patients with acute ischemic stroke:results of a randomized phase 2 trial[J]. Stroke,2005,36(4): 880-890.
[124]Abciximab in Emergency Treatment of Stroke Trial(AbESTT-II) Investigators. Emergency administration of abciximab for treatment of patients with acute ischemic strokerResults of an international phase Ⅲ trial[J]. Stroke,2008,39(1):87-99.
[125]微纤溶酶Ⅱ期临床获得正性结果[J].国外药讯,2008,(11)：11-12.
[126]Morris DC, Li Zhang L, Zhang ZG, et al. Extension of the therapeutic window for recombinant tissue plasminogen actitor with argatroban in a rat model of embolic stroke[J]. Stroke,2001,32(11):2635-2640.
[127]LaMonte M P, Nash ML, W ang DZ, et al. Extension of the therapeutic window for recombinant tissue plasminogen activator with argatroban in a rat model of embolic stroke, argatroban antieoagulation in patients with acute ischemicstroke(ARGIS-1):a randomized, placebo-controlled safety study[J]. Stroke,2004,35(7):1677-1682.
[128]Danton G H, Dietrich W D. Inflammatory mechanisms after ischemia and stroke[J]. Neuorpathol ExpNeurol,2003,62(2):127-136.
[129]Jiang N, Chopp M, Chahwala S.Neutrophil inhibitory factor treatment of focal cerebral ischemia in the rat[J]. Brain Res,1998,788(1-2):25-34.
[130]Hara H, Friedlander R M, Ganliardim V, et al. Inhibition of interleukin-1 beta converting enzyme family proteasese reduces ischemic and excitotoxic neuronal damage[J]. Proc Natl Acad Sci USA,1997,94(5):2007-2012.
[131]Stroemer R P,Rothwell N T. Exacerbation of ischemlic brain damage by localized striatal injection of intrleukin-1 β in the rat. J Cereb Blood Flow[J].Metab,1998,18(8):833-839.
[132]刘清和,张兆辉,余绍祖.抗TNF-α单克隆抗体对局灶性脑缺血作用的初步研究[J].中国神经精神疾病杂志,1999,25(3)：169-170.
[133]Emsley H C, Ynelt P J Inflammation and infection in clinical stroke. J Cereb Blood Flow[J].Metab,2002,22(12):1399-1419.
[134]李文,包仕尧.碱性成纤维细胞生长因子治疗脑梗死研究进展[J].国外医学脑血管疾病分册,1999,7(4)：227.
[135]Shinn Z L,Holler B J, KaPlan P, et al. Osteogenic protein-1 Protects against cerebral in farction induced by MCA ligation in adult rats[J]. Stroke,1999,30(1):126-133.
[136]Poon WS, Lu Gang KS, et al. Migration of bone marow stem cellsin ischemic brain [J].Acta Neurochir Suppl,2006,99:123-124.
[137]Ding S, Messam CA, Li P, et al.Murine brain progenitor cells have the ability to differentiate into functional neurons and integrate into the CNS[J].Cell Transplant,2006,15(8):699-710.
[138]Me Leod M, Hong M, Sen A,et al.Transplantation Of bioreactor-produced neural stem cells into the rodent brain[J]. Cell Transplant,2006,15(8):689-697.
[139]Li Y, Chen J, Chen XG, et al. Human marow stromal cell therapy for stroke in rat:neurotrophins and functional recovery[J].Neurology,2002,59(4):514-523.
[140]Yadav JS, Wholey M H, Kuntz RE, et al. Protected carotid2artery stenting versus endarterectomy in high-risk patients[J].N Engl J Med,2004,351:1493-1501.
[141]CAVATAS investigators. Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Artery TransluminalAngioplasty Study (CAVATAS):a randomized trial[J]. Lancet,2001, 357:1729-1737.
[142]Hobson RW. CREST(Caro tid Revascu larization Endarterectomy versus Stent Trial):background, design, and current status[J]. Semin Vase Surg,2000, 13:139-143.
[143]Mas JL, Chatellier G, Beyssen B. Endarterectomy versus stenting in Patients with Symptomatic Severe Carotid Stenosis[J]. N Engl J Med,2007,355: 1660-1671.
[144]凌锋.缺血性脑血管病介入治疗现状和存在的问题[J].实用医院临床杂志,2008,5(2)：3-5.
[145]Cruz-Flores S, Diamond AL. Angiop lasty for in tracranial artery stenosis[J]. Cochrane Database of Systematic Reviews,2006,3:1500-1505.
[146]Adarns H, Adams R, Del Zoppo G, et al. Guidelines for the early management of patients with ischemic stroke:2005 guidelines update a scientific statemen from the stroke council of the american heart association/american stroke association[J]. Stroke,2005,36(4):916-923.
[147]Smith WS, Sung G, Starkman S, et al. Safety and efficacy of embolevtomy in acute ischemic stroke[J]. Stroke,2005,36:1432-1440.
[148]Smith WS. Safety of mechanical, thrombectomy and intravenous tissue plasminogen activator in acute ischemic stroke. Results of the multi mechanical embolus removal in cerebral ischemia(MERCI)trial[J].AJNR,2006,27:1177-1182.
[149]1 Rha JH, Saver JL. Recanalization as a surrogate outcome measure in thrombolitic clinical trials:a meta-analysis[J]. Stroke,2003,34:317.
[150]Gonzdlez A, Mayol A, Eva Martinez E, et al. Mechanical thrombectomy with snarei in patients with acute ischemic stroke [J]. Neuroradiology,2007,49:365-372.
[151]Chris Wei hl, R Loch Macdonald, et al. Gene therapy for cerebrovascular disease[J]. Neurosurgery,1999,44(2):239-246
[152]杨莉,高颖昌,赵志刚.鼻腔给药的研究进展[J].中国药学杂志,2006,22(11)：1685-1688.
[153]陆彬.药物新剂型与新技术[M].2版.北京：人民卫生出版社,2005.
[154]王东兴,高永良.鼻腔给药新剂型研究进展[J].中国新药杂志,2002,11(8)：589-592.
[155]张翔,郝伟,宁斌,等.中药鼻腔给药制剂的研究进展[J].山东大学耳鼻喉眼学报,2005,19(12)：412-413.
[156]金方,谢保源,施丽西.用于全身治疗的鼻腔给药系统[J].中国医药工业杂志,1998,29(3)：137-141.
[157]石森林,徐莲英.脑部疾病的鼻腔给药研究[J].中药新药与临床药理,2004,15(3)：145-148.
[158]程巧鸳,朱文静.鼻腔给药的生物利用度研究进展[J].国外医学：药学分册,2004,37(3)：168-172.
[159]周金英.中药药理学[M].上海：上海科学技术出版社,1985,190.
[160]许莲英.冰片的药理研究[J].中成药研究,1986,(3)：1.
[161]陈铁峰.冰片促四甲基吡嗪吸收[J].中国药理学报,1990,11(1)：42.
[162]汪春,陈宏珪,雷娓娓.脑醒喷鼻剂治疗急性缺血性中风的实验研究[J].广州中医药大学学报,1999,16(2)：119-122.
[163]刘煜德,吴伟,陈宏珪.脑醒冲剂对大鼠脑组织缺血再灌注保护作用的实验研究[J].新中医,2002,34(1)：72-74.
[164]吴伟,陈宏珪,刘煜德.脑醒冲剂对人鼠全脑缺血及再灌注皮层脑电位的影响[J].中药新药与临床药理,2002,13(6)：379-380.
[165]李荣,吴伟,陈宏硅,等.脑醒喷鼻剂对人鼠脑缺血再灌注损伤脑组织超微结构的影响[J].中药新药与临床药理,2003,14(1)：10-13.
[166]孙寒静,黄天来,宓穗卿,等.芎冰喷雾剂脑内药物动力学研究[J].中药新药与临床药理,2003,14(3)：177-179.
[167]刘煜德,孙寒静,李荣,等.冰片对川芎嗪经鼻腔吸收入脑的影响[J].中国中药杂志,2008,33(3)：259-261.
[168]汪春,陈宏珪,吴伟.脑醒喷鼻剂治疗急性缺血性中风的临床观察[J].中药新药与临床药理,2000,11(6)：333-335.
[169]杨开清,陈宏硅,黄衍寿.脑醒冲剂治疗急性缺血性中风的临床研究[J].广州中医药大学学报,2001,18(3)：224-225.
[170]杨开清,李荣,陈宏硅.脑醒喷鼻剂治疗急性缺血性中风66例[J].广州中医药大学学报,2003,20(1)：28-30.
[171]李荣,吴伟,刘煜德,等.脑醒喷鼻剂对脑梗塞患者血管内皮功能及血液流变学的影响[J].辽宁中医杂志,2005,32(9)：877-888.
[172]杨开清,李荣,陈宏珪.脑醒喷鼻剂对缺血性中风患者血管内皮细胞功能的影响[J].中药新药与临床药理,2005,16(2)：139-141.
[173]徐慧聪.芎冰喷雾剂对椎—基底动脉供血不足的即时疗效[J].中西医结合心脑血管病杂志,2006,4(5)：388-390.
[174]洪创雄,明康文.芎冰喷雾剂合参麦注射液治疗椎基底动脉缺血性眩晕临床观察[J].实用医学杂志,2003,19(8)：932-933.
[175]徐辉碧,谢长生.纳米技术在中药研究中的应用[J].中国药科大学学报,2001,32(8)：161-165.
[176]刘喆,赖新生.大脑中动脉闭阻脑缺血模型大鼠的建立与评价[J].中国行为医学科学,2005,14(10)：877.
[177]Longa E Z, Weinstein P R, Carlson S,et al.Reversible middle cerebral artery occlusion without craniectomy in rats [J].Stroke,1989,20(1):84-91.
[178]徐立新,袁芳.改良的大鼠脑局部缺血模型[J].中国康复理论与实践,2005,11(1)：23-24.
[179]Bederson J B, Pitts LH, Tsuji M, et al.Rat middle cerebral artery occlusion :evaluation of the model and development of a neurologic examination [J]. Stroke,1986,17:472-476.
[180]Petullo D, Masonic K, Lincoln C, et al. Model development and behavioral assessment of foeal cerebral ischemia in rats[J]. Life Sciences,1999,64:1099-1108.
[181]张荣嫒,张宏伟,尚爱加.大鼠大脑中动脉缺血再灌注模型制备及行为学评价标准的改进[J].军医进修学院学报,2008,29(5)：422-423.
[182]Hartfield RH, Mendelow AD, Perry RH, et al. Triphenyltetrazoliurn chloride (TTC)as a marker for ischemic changes in rat brain following permanent middle cerebral artery occlusion[J].Neuropathol Appl Neurobiol,1991,17:61-67.
[183]Naddas M M, Sandriter TK. Microscopic identification of early myocardial infarcts by dehyaroge alterations[J]. Am J Pathol,1963,42:379-405.
[184]周剑,高培毅,李小光.实验性大鼠脑血肿周围脑组织血流变化的CT灌注成像研究[J]..中华放射学杂志,2005,39(5)：538-543.
[185]刘鹏斌,常丹,宋正川.氯胺酮麻醉对大鼠局灶性脑缺血模型病理结局的影响[J].第四军医大学学报,2006,27(3)：212-214.
[186]Eamshaw WC, Martins LM, Kaufinann SH. Mammalian caspase:structure, activation,suhstrates, and functions during apoptosi[J]s. Annu Rev Biochem, 1999,68:382-424.
[187]Ferrer I,Friguls B, DalfoE, et al. Caspase-dependent an caspase-independent signaling of apoptosis in the penumbr following middle cerebml artery occlusion in the adult rat[J].Neuropathol Appl Neurobiol,2003, 29(5):472-481.
[188]Solarogu I, Tsubokawa T, Cahill J, et al. Anti-apoptotic effect of granulocyte colony stimulating factor after focal cerebral ischemia in the rat[J].Neuroscience,2006,143(4):965-74.
[189]Howard Y. Proteases for cell suicide:functions and regulation of caspases [J].Mierobiol Mol Biol Rev,2000,64(4):821-846.
[190]刘天会,陈瑞,杜艳玲.小鼠短暂前脑缺血海马中半胱天冬酶-3酶原表达的变化[J].中国生物化学与分子生物学报,2006,2(1)：55-58.
[191]Reed J C.Apoptosis based thempies[J]. Nat Rev Drug Discov.2002,1(5):111-121.
[192]Papadopoulos MC, Krishna S, VerkmanAS. Aquaporin water channels and brain edema [J].Mt SinaiJMed,2002,694:242-248.
[193]Aoki K, Uchihara T, Tsuchiya K, et al. Enhanced expression of aquaporin-4 in human brain with infarction[J]. Acra Neuropathol,2003,106(2):121-124.
[194]Manley GT, FujimuraM, Ma T, et al. Aquaporin-4 deletion in mice reduces brain edema after acute water introxication and ischemic stroke [J]. NatMed, 2000,6(2):159-163.
[195]Amberger A, Weiss H, Hailer T, et al.A subpopulatio of mitochondria prevents cytosolic calcium overload in endothelial cells after cold ischemia/ reperfusion[J]. Transplantation,2001,71(12):1821-1827.
[196]张拥波,董为伟,王得新.caspase-3抑制药和钙拮抗药联合应用对氧糖剥夺性神经元缺血损害的保护作用[J].中国现代神经疾病杂志,2007,7(1)：57-60.
[197]Takadera T, Ohyashiki T.Apoptotic cell death and caspase-3(CPP32) activation induced by calcium ionophore at low concentrations and their prevention by nerve growth factor in PC12 cells[J].Eur J Biochem,1997,249: 8-12.
[198]李燕华,孙善全,李吕力.低渗状态下星形胶质细胞AQP 4mRNA的表达和Ca2+浓度的关系[J].中风与神经疾病杂志,2005,22(4)：292-296.
[199]滕伟禹,田力,刘宏丽,等.水蛭素、尼膜同对大鼠实验性脑出血后AQP4mRNA表达及脑水肿的作用研究[J].中国现代医学杂志,2006,16(9)：1290-1293.
[200]李露斯,刘之荣,肖桃元,等.大鼠慢性脑血流灌注不足脑的病理组织学和超微结构变化[J].第三军医大学学报,1999,21：1042-1045.
[201]John S, Strven P.Immunophilins mediate the neuroprotective effects of FK506 in focal cerebral ischemia[J].Nature,1994,371:326-339.
[202]DeGraba TJ. The role of inflammation after acute stroke:utility of pursuing anti-adhesion molecule therapy[J]. Neurology,1998,51:62-68.
[203]Malik, ST. The activity of TNF in experiment cancer models In Beutler Red Tumor Necrosis Factors[J]. New York:Raven Press,1991,407:23
[204]Zaremba J, Skrobanski P, Losy J. Tumour necrosis factor-α is increased in the cerebrospinal fluid and serum of ischemic stroke patients and correlates with the volume of evolving brain infarct[J]. Biomed Pharmacother,2001,55:258-263.
[205]Vila N, Castillo J, Davalos A, et al. Proinflammatory cytokines and early neurological worsening in ischemic stroke[J]. Stroke,2000,31:2325-2329.
[206]Barone FC, Arvin R, White RF, et al. Tumor necrosis factor-α. A mediator of focal ischemic brain injury[J].Stroke,1997,28:1233-1244.
[207]Fan L, Young PR, Barone FC,et al. Experimental brain injury induces expression of interleukin-1 beta messenger RNA in the rat brain[J].Mol Brain Res,1995,30(1):125-130.
[208]Rothwell NJ. Cytokines-killers in the brain?[J] J Physiology,1999,514(1) :3-17.
[209]中华医学会神经病学分会.脑卒中患者临床神经功能缺损程度评分标准[J].中华神经科杂志,1996,29：381-383.
[210]王拥军,颜振瀛,王新,等.脑卒中患者神经功能缺损程度评分标准的修订以及信度和效度研究[J].世界医学杂志,2002,6(8)：16-20.
[2]王新陆.脑血辨证[M],北京：中国医药科技出版社,2002：82-99.
[3]丁元庆.卢尚岭调气为主治疗急性中风经验[J].山东中医药大学学报,2000,24(1)：43-44.
[4]赵海滨,马东信,沈承玲.邵念方“中风无风论”初探[J].中国中医急症,2001,10(1)：40-41.
[5]张宏伟,刘东霞.张学文中医世家经验辑要[M].西安：陕西科学技术出版社,2004：79-82.
[6]王辉,刘金榜.陶根鱼主任医师治疗中风后遗症经验总结[J].国医论坛,2007,22(2)：13-14.
[7]李奎生.试论活血化瘀法在中风治疗中的地位[J].医药世界,2007,11(2)：103-104.
[8]孙丽红.中风血瘀致病说文献探微[J].上海中医药杂志,2007,41(11)：68-70.
[9]张国平,刘华,别晓东.不同类型中风血瘀证患者血液流变学和凝血谱指标的研究[J].全科医学临床与教育,2006,4(3)：204-210.
[10]藏燕坤.活血化瘀法治疗出血性脑卒中急性期50例[J].河南中医,2007,17(9)：36.
[11]周鲁,张庆,宋航,等.治疗中风的复方用药规律研究[J].辽宁中医杂志,2007,34(1)：8-9
[12]唐映红,邓常青,刘旺华,等.补阳还五汤4类有效部位对局灶性脑缺血大鼠脑梗死体积的影响[J].中草药,2005,36(2)：236.
[13]王新高,童萼塘,孙圣刚.补阳还五汤对大鼠脑缺血再灌注损伤后血脑屏障的影响[J].中国动脉硬化杂志,2005,13(5)：579.
[14]彭康,孙忠.补阳还五汤对中风后遗症“气虚血瘀”大鼠脑组织三磷酸腺苷及二磷酸腺苷和单胺类神经递质的影响[J].中国临床康复,2004,8(10)：1908.
[15]张淑萍,梁燕,邓常青.补阳还五汤及其有效部位对大鼠脑缺血再灌注后Caspase表达的影响[J].中草药,2006,37(7)：1041.
[16]刘柏炎,蔡光先,林琳,等.补阳还五汤对大鼠局灶性脑缺血后神经干细胞影响的初步研究[J].中国临床康复,2004,8(22)：4532.
[17]高兴来.通腑泻下法在中风病中的运用[J].实用中医内科杂志,2008,22(9)：68-69.
[18]王永炎.化痰通腑法治疗缺血性中风158例疗效观察[J].中国医药学报
,1986,1(2)：22.
[19]李凤玲.化痰通腑汤灌肠治疗中风病急性期痰热腑实证158例[J].中医杂志,2008,49(7)：637.
[20]王永炎.中医内科学[M].上海：上海科学技术出版社,1997,124-132.
[21]赵孔华,张园.缺血性脑中风的发病机理探讨[J].河南中医,2006,26(7)：7.
[22]祝美珍.缺血性中风病证本质的客观化研究与探讨[J].中西医结合心脑血管病杂志,2006,4(9)：775.
[23]张佛明,张新春,黄燕.痰瘀同治法治疗缺血性中风Meta分析[J].南京中医药大学学报,2007,23(6)：358-361.
[24]麻志恒.化瘀祛痰汤治疗脑梗塞的临床疗效观察[J].中成药,2009,31(2)：177-179.
[25]胡怀强,周永红,王新陆.试论滋补肝肾是促进中枢神经再生的重要方法[J].天津中医药,2009,26(4)：296-298.
[26]许宏霞,曹晓岚.肾虚与中风后抑郁发病的关系浅析[J].中西医结合心脑血管病杂志,2007,5(8)：725-726.
[27]张俊平,武荣芳,王丽,等.补肾益气活血法与缺血性中风[J].中国中医急症,2008,17(2)：193-194.
[28]邓启玉.补肾活血法为主治疗缺血性中风恢复期80例[J].实用中医药杂志,2008,24(1)：16-17.
[29]李家邦,李瑛,熊国良,等.肝阳化风证病理生理学基础的进一步研究[J].湖南医科大学学报,2000,25(4)：3.
[30]陈孝银,肖蒲鲜,范隆昌.肝阳上亢者部分免疫指标变化的检测分析[J].四川中医,2000,18(3)：7.
[31]赵继伟.缺血性中风急性期中医治疗体会[J].中西医结合心脑血管病杂志,2004,2(2)：119.
[32]李炯侠.自拟平肝熄风汤治疗急性缺血性中风30例[J].陕西中医,2008,29(2)：168-169.
[33]刘晓俊,高敏,黄汉超,等.调肝治法干预中风后抑郁症患者对汉密尔顿抑郁量表及血浆皮质醇水平的影响[J].现代中西医结合杂志,2008,17(7)：3101-3102.
[34]韩凤芹,王亚利,邢继军.潜阳熄风胶囊治疗中风病先兆证85例临床观察[J].辽宁中医杂志,2008,35(10)：1508-1509.
[35]常富业,王永炎.中风病毒邪论[J].北京中医药大学学报,2004,27(1)：3-6.
[36]吴子辉,吴林,毒为出血性中风至笃之本[J].广西中医药,2005,28(1)：49-50.
[37]许宏霞,曹晓岚,王敏.对缺血性中风病急性期炎症反应的中西医认识[J].中西医结 合心脑血管病杂志,2007,5(2)：155-157.
[38]黄宇虹,张伯礼.中风病发病时中医证候特点浅析[J].天津中医药大学学报,2007,26(2)：59-60.
[39]张占军,李澎,王忠.精制清开灵干预MCAO再灌注损伤的药效及机制研究[J].中国病理生理杂志,2006,22(11)：2105-2109.
[40]沈强,刘亚敏,张赐安,等.麝香、冰片对全脑缺血再灌注大鼠脑微血管内皮细胞ICAM-1表达的影响[J].中西医结合心脑血管病杂志,2003,1(3)：36.
[41]李小球,刘煜德,梁云花.开窍法对骨髓基质干细胞颈动脉内移植治疗缺血性中风的增效作用[J].中国中医急症,2008,17(6)：804-805.
[42]方永奇,魏刚,吴启端,等.石菖蒲醒脑开窍作用物质基础及其作用机制研究[J].医学研究杂志,2007,36(9)：60.
[43]钮跃贞.鼻腔给药的研究概况[J].中国新药与临床杂志,2001,20(5)：381-383.
[44]杨开清,李荣,陈宏珪.脑醒喷鼻剂治疗急性缺血性中风66例[J].广州中医药大学学报,2003,20(1)：28-30.
[45]李荣,吴伟,陈宏硅.不同剂量脑醒喷鼻剂对再灌注损伤脑组织自由基及一氧化氮合酶变化的干预[J].中国临床康复,2005,9(21)：254-256.
[46]李荣,吴伟,刘煜德,等.脑醒喷鼻剂对脑缺血再灌注损伤抗炎保护作用的实验研究[J].新中医,2005,35(8)：93-94.
[47]Danton G H, Dietrich W D. Inflammatory mechanisms after ischemia and stroke [J]. Neuropathol ExpNeurol,2003,62:127-37.
[48]Hess D C,Howard E, Cheng C, et al.Hypcrtonic mannitol loading of NF-κB transcription factor decoys in human brain microvascular endothdial cells blocks upregulation of ICAM-1[J]. Stroke,2000,31:1179-86.
[49]Gibson C L, Jones NC, Prior MJ, et al. G-CSF suppresses edema formation and reduces interleukin-1 beta expression after cerebral ischemia in mice[J]. Neuropathol Exp Neurol,2005,64(9):763.
[50]Zhans J T, Wu W P, Zhans FY. Interleukin-1 β Converting Enzyme Gene Expression after Cerebral Ischemia Repefusion[J]. J Mil Med,2002,27:56-58.
[51]Bin X, Liu X W, Liu X W. Interleukir-1 Chansing in Cerebral Cortex and Hippocampi after all Brain Ischemia Reperfusion[J].Clin Recovery,2002,6: 50-51.
[52]Auan S M, Parker L C, CO lins B. Cortical Cel Death Induced by IL-1 is Mediated Via Actions in the Hypothalamus of the Rat[J]. Proc Natl Acad Sci USA, 2000,97:5580-5581.
[53]Hillhouse E W, Kida S, lannoui F. Middle cerebral artery occlusion in the rat causes a biphasec production of immunoreactive interleukin-1 β the erebral cortex[J]. Neurosci Let,1998,249(23):177-179.
[54]Fabian R H, Perez-Polo JR, Kent TA. Electrochemical monitoring of supeorxide anion production and cerebral blood flow:effect of interleukin-1 β pretreatment in a model of focal ischemia and reperfusion[J]. J Neurosci Res,2000,60 (6):795-803.
[55]All C, Nicole O, Docagne F, et al. Ischemia-induced interleukin-6 as a potential indogenous neuroprotective cytokine against NMDA receptor mediated exitotoxicity in the brain[J].J Cereb Blood Plow Metab,2000,20(6):956-966.
[56]Suzuki S, Tanaka K, Nogawa S, et al. Expression of interleukin-6 is suppressed by inhibition of voltage sensitive Na+/Ca2+ channels after cerebral ischemia [J]. Neuroreport,2000,11(11):2565-2569.
[57]Loddick S H, Tumbull A V, Rothwell N J, et al. Cerebral interleukin-6 is neuro protective during permanent focal cerebual ischemia in the rat[J].J Cereb Blood Flow Metab,1998,18(2):176-179.
[58]Vilan, Castillo J, Davalos A, et al. Proinflammatory cytokines and early neurological worsening in ischemic stroke [J]. Stroke,2000,31(10):2325-2329.
[59]Zarembra J. Contribution of tumbor necrosis factor alpha to the pathogensis of stroke [J]. Folia Morphol(Warsz),2000,59(3):137-143.
[60]Yamasaki Y,ItoyamaY,Kogure K.Involvement of cytokine porductionin pathogenesis of transient cerebral ischemic damage[J]. Keio J Med,1996,45 (3):225-229.
[61]Wang CX, Shuaib A. Involvement of inflammatory cytokines incentral nervous system injury[J]. Pros Neurobiol,2002,67:161
[62]Abillerira S, Montaner J, Molina CA, et al. Matrix metalloproteinase-9 pretreatment level predictsin-tracranial hemorrhagic complications after thrombolysis in human stroke [J]. Circulation,2003,107:598-600.
[63]Chen L, Vicaut E, Sercombe RI. Polymorphonuclear leukocyte activation induces cerebral hypo-perfuslon in rats in the absence of previous ischemia-repefusion damage [J]. Neurosci Lett,2002,331:2037
[64]项洁,沈霞,耿德勤.肿瘤坏死因子-α在大鼠脑缺血再灌注中的表达及对神经细胞凋亡的影响[J].中国临床康复,2004,8(28)：6094-6095
[65]Botchkina GL, Geimonen E, Bilof ML, et al. Loss of NF Kappa B activity during cerebral ischemia and TNF cytotoxicity[J].Mol Med,2002,5(6):372-381.
[66]Zhai Q H, Fruell N, Chen F J, et al. Gene expression of IL-10 in relationship to TNF-alpha,IL-1 beta and IL-2 in the rat brain following middle cerebral artery occlusion[J]. J Newrol Sci,2003,152(2):119-124
[67]Barone FC, Arvin B, White RF, et al. Tumor necrosis factor-α:amediator of focal ischemic brain injury[J]. Stroke,2003,28(6):2733.
[68]Uno H, Matsuyama T, AkitaH, et al. Induction of tumor necrosis factor-α in the mouse hippocampus following transient forerbrain ischemia[J]. Cereb Blood Flow Metab,2004,17(5):49.
[69]Konemoto Y, Nakase H, Akita N, Sakald J.Elects of anti-inter-celular adhesion molecule-1 antibody on reperfusion iniury included by late reperfusion in the rat middle cerebral artery occlusion model [J]. Neurosygery, 2002,51:1034-1042
[70]夏斌,邵福源.CD11/CD18在脑缺血／再灌注损伤中的作用[J].国外医学,脑血管疾病分册,2000,8(3)：133.
[71]Zhang R L, Chopp M, Jiang N, et al. Anti-intercellular adhesion molecule-1 antibody reduces ischemic cell damage after transient but not permanent middle cerebral artery occlusion in the wistar rat [J]. Stroke,2002,26(8):1438-1447.
[72]Frijus C J, Kappelle L J. Inflammatory cell adhesion molecules ischemic cerebrovascular disease[J]. Stroke,2002,33(8):2115-2122.
[73]Berti R, Williams A J, Mofet J R, et al. Quantitative real-time RT-PCR analysis of inflammatory gene expression associated with ischemia-reperfusion brain injury[J].J Cereb Blood Flow Metab,2002,22(9):1068-1079.
[74]Zhang R, Chopp M, Zhang Z, et al. The expression of P-selectins and E-selectins in three models of middle cerebral artery occlusion[J]. Brain Research,2002,785(2):207-214.
[75]Haring H, Berg E L, Tsurushita N, et al. E-selectin appears in nonischemic tissue during experimental focal cerebral ischemia [J]. Stroke,2003,27(8): 1386-1392.
[76]Lee S R, Lo E H. Induction of caspase-mediated cell death by matrix metallo proteinases in cerebral endothelial cells after hypoxia-reoxygenafion[J]. J Cereb Blood Flow Metab,2004,24:720-727.
[77]Magnoni S, Baker A, George SJ. Diferenfial alterationsinthe expression and activity of matrix metallopmteinases 2 and 9 after transient cerbral ischemia in mice[J].Neurobiol Dis,2004,17:188.
[78]Shimakura A, Kamanaka Y, Ikeda Y,et al.Neutrophil elastase inhibition reduces cerebral ischemic damage in the middle cerebral artery occlusion[J]. Brain Res,2000,858:55-60.
[79]Tonai T, Shiba K, Taketani Y, et al. A neutrophil elastase inhibitor reduces neurologic damage after spinal cord injury in rats[J]. Neurothem,2001,78: 1064-1072.
[80]Bai W T, Chen LJ, Expression of platelet activating factor receptor gene during focal reversible ischemia of rat brain[J]. Stroke and Nervous Diseases,2005,12:2.
[81]Park TS, Gonzales ER, Giay JM. Platelet-activating factor mediates ischemia included leukocyte-endothelial adherence in new born pig brain[J]. Comb Blood Flow Metab,1999,19:417-424.
[82]Takai Y, Kishimoto A, Inoue M, et al. Studies on acyclic neurotide independent protein kinase and its proenzyme in mammalisan tissue[J]. Biol Chem,2001,252(61):7603.
[83]Nakayama R, Yano T, Ushijima K, et al. Effects of dantrolene on extracellular glutamate concentration and neuronal death in the rat hippocampal CAI region subjected to transient ischemia[J]. Anesthesiology, 2002,96(3):705-710.
[84]Nishizawa Y. Glutamate release and neuronal damage in ischemia[J]. Life Sci,2001,69:369-381.
[85]Dawso V L, Dawson TM, Batley DA, et al. Mechanism of nitric oxide-mediated neurotoxity in primary brain cultures[J]. J Neurosic,2003,13(6):2651-2661.
[86]Radi R, Backman J S, Bush K M, et al. Peroxynitite-induced membrane lipid peroxidation:the cytotoxic potential of superoxide and nitric oxide [J]. Arch Biochem Biophy,2001,288:481-487.
[87]Me Donald LJ, Moss J. Stimulation by nitric oxide of an NAD linkage to glyceraldehydes-3-phosphate dehydrogenase[J]. Proc NatlAcad Sci USA,2000,90: 6238-6241.
[88]Kontos H A. Oxygen radicals in cerebral ischemia:the 2001 Willis lecture [J]. Stroke,2001,32:2712-2716.
[89]Bates B,Hirt L,Thomas SS,et al. Neurotorphin-3 promotes cell death induced in cerebral ischemia,oxygen-glucose deprivation, and oxidative stress:possible involvement of oxygen free redicals[J]. Neuorbiol Dis,2002, 9(1):24-37.
[90]Kokubo Y, Matson GB, Liu J, et al. Correlation between changes in apparent difusion efficient and induction of heat shock protein, cell-specific injury marker experssion, and protein synthesis reduction on diffusion-weighted magnetic resonance images after temporary focal cerebral ischemia in rats[J]. J Neurosurg,2002,96(6):1084-1093.
[91]Ma RH, Wang YJ, Qu H, et al. Assessment of the early efectiveness of a stroke unit in comparison to the general ward[J]. Chin Med J,2004,117:852-855
[92]Liu XF, Fawcett JR, Thome RG, et al. Non-invasive intranasal insulin-like growth factor-Ⅰ reduces infarct volume and improve sneurologic function in rats following middle cerebral artery occlusion [J]. Neuro sci Lett,2001,308: 91-94.
[93]Yenari MA, Iwayama S, Cheng D, et al. Mild hypothermia attenuates eytochromec release but does not alter Bcl-2 expression or caspase activation after experimental stroke[J].J Cereb Blood Flow Metab,2002,22:29.
[94]Mrsic Pelcic J, Pelcic G, Vitezic D. Hyperbaric oxygen treatment:the influence on the hippocampal superoxide dismutase and Na+-K+-ATPase activities in global cerebral ischemia-exposed rats[J]. Neurochem lnt,2004,44:585.
[95]Li Y, Zhou C, Calvert J W, et al. Multiple efects of HBO on HIF-la expression and apoptotie genes in global ischemia rat model[J]. Neurol,2005,191:198.
[96]Lou M, Eschenfelder CC, Herdegen T, et al. Therapeutic window for use of hyperbaric oxygenation in focal transient ischemia in rats[J]. Stroke,2004, 35:578.
[97]张立群,陈洁丽,程众,等.尼莫地平对局灶性脑缺血.鼠脑血浆蛋白的影响[J].中风与神经疾病杂志,2001,18：300.
[98]Avshalumov M V, Rice ME. NMDA receptor activation mediates hydrogen peroxide-induced pathophysiology in rat hippocampal slices[J]. J Neurophysiol ,2002,87(6):2896-2903.
[99]Zalish M, Lavie V. Dexanabinol (HU 211) has a beneficial effect on axonal sprouting and survival after rat optic nerve crush injury [J]. Vision Res,2003, 43(3):237-242.
[100]Croxford J L.Therapeutic potential of cannabinoids in CNS disease [J]. CNS Drugs,2003,17(3):179-202.
[101]Kawasaki-Yatsugi S. Neuroprotective effects of an AMPA receptor antagonist YM872 in a rat transient middle cerebral artery occlusion mode[J]. Neuropharmacology,2000,39(2):211-217
[102]DeSarro G. Comparative anticonvulsant activity of some 2,3 benzodiaze pinederivative sinrodents[J]. Pharmacol Biochem Behav,2003,74(3):595-602
[103]毛春.镁对缺血性脑损伤的神经保护作用[J].国外医学：脑血管病分册,2000,8(10)：33.
[104]Lin J Y Chung S Y, Lin M C, et al. Efects of magnesium sulfate of energy metabolites and glutamate in the cortex during focal cerebral ischemia and reperfusion in the gerbil monitored by a dural-probe micro dia lysis technique[J]. Life Sci,2002,71(7):803-811.
[105]Kinoshita Y,Ueyama T, Senba E, et al. Expression of c-fos, heat shock protein 70, neurotropins, and cyclooxygenase-2 mRNA in response to focal cerebral ischemia/reperfusion in rats and their modification by magnesium sulfate[J]. J Neurotrauma,2001,18(4):435-445
[106]Lees K R. Does neuroprotection improve stroke outcome? [J]. Lancet,1998, 351(9114):1447-1448.
[107]潘家枯,张磊.脑梗死的药物治疗[J].中国新药与临床杂志,1999,18(4)：234.
[108]Diener H C, Hacke W, Hennerici M, et al. Lubeluzole in acute ischemic stroke:a double-blind placebo controlled phase II trail[J]. Stroke,1996,27: 76-81
[109]栗秀初,孟锦立.第16届世界神经科大会中有关缺血性中风的某些诊疗新观点和新措施简介.中风与神经疾病杂志,1998,15(2)：125-128.
[110]Leker R R, Neufeld M Y. Anti-epileptic drugs as possible neuroprotectantss in cerebral ischaemia[J]. Brain ResRev,2003,42(3):187-203.
[111]Wahlgrren N G, Pharmacological treatment of acute stroke [J]. Cerebralvasc Dis,1997,7(Suppl3):24-30.
[112]冯涛,王拥军,朱克.糖皮质激素受体阻断剂抑制成年雄性大鼠持续性局灶脑缺血后Caspase-3基因表达[J].卒中与神经疾病杂志,2004,11：208-212.
[113]Wu T W, Zeng L H, W u J,Fung KP.MCI-186:further histochemical and biochemical evidence of neuorprotection[J]. Life Sci,2002,67(19):2387-2393
[114]陈静宜.一种改善脑卒中病残性药物——依达拉奉[J].中国临床药学杂志,2002,11(4)：244-245.
[115]Bemeur Cste Marie L, Desjardins P, et al. Expression of superoxide dismutase in hyperlycemia focal cerebral ischemia in the rat[J]. Neurnohem lnt,2004:1167-1174.
[116]Danielisova V, Nemethova M, Burda J. The protective effect of aminoguanidineon cerebral ischemic damage in the rat brain[J]. Physiol Res,2004,53:533-540.
[117]李建军,孙琦,曹辉,等.神经节苷脂对大鼠脑缺血再灌注损伤的脑保护作用[J].临床神经病学杂志,2006,19：124-126.
[118]祝伟华,勾振堂,齐立伟,等.雌激索对大鼠脑缺血再灌注损伤脑皮质EAA含量的影响[J].中风与神经疾病杂志,2003,20：231-232.
[119]Regan M H. The effect of topical insulin on the release of excit otoxican do the raminoacids from the rat cerebral cortex during strepto-otocin induced hyperglycemic ischemia[J]. Brain Res,2000,872(1/2):29-36.
[120]Belayev L, liu Y, et al. Human albumin therapy of acute ischemic stroke:marked neuroprotective efficacy at moderate doses and with a broad therapeutic window[J]. Stroke,2001,32(2):553-560.
[121]Chest,2008,133 (6 Suppl):630-669.
[122]田凤石,张秀泉.老年急性缺血性心脑血管病患者血小板表面糖蛋白受体GPIIb/GPIlla的动态变化[J].中国危重病急救医学,2000,10(5)：304-305.
[123]Abciximab Emergent Stroke Treatment Trial(AbESTT) Investigators. Emergency administration of abciximab for treatment of patients with acute ischemic stroke:results of a randomized phase 2 trial[J]. Stroke,2005,36(4): 880-890.
[124]Abciximab in Emergency Treatment of Stroke Trial(AbESTT-II) Investigators. Emergency administration of abciximab for treatment of patients with acute ischemic strokerResults of an international phase Ⅲ trial[J]. Stroke,2008,39(1):87-99.
[125]微纤溶酶Ⅱ期临床获得正性结果[J].国外药讯,2008,(11)：11-12.
[126]Morris DC, Li Zhang L, Zhang ZG, et al. Extension of the therapeutic window for recombinant tissue plasminogen actitor with argatroban in a rat model of embolic stroke[J]. Stroke,2001,32(11):2635-2640.
[127]LaMonte M P, Nash ML, W ang DZ, et al. Extension of the therapeutic window for recombinant tissue plasminogen activator with argatroban in a rat model of embolic stroke, argatroban antieoagulation in patients with acute ischemicstroke(ARGIS-1):a randomized, placebo-controlled safety study[J]. Stroke,2004,35(7):1677-1682.
[128]Danton G H, Dietrich W D. Inflammatory mechanisms after ischemia and stroke[J]. Neuorpathol ExpNeurol,2003,62(2):127-136.
[129]Jiang N, Chopp M, Chahwala S.Neutrophil inhibitory factor treatment of focal cerebral ischemia in the rat[J]. Brain Res,1998,788(1-2):25-34.
[130]Hara H, Friedlander R M, Ganliardim V, et al. Inhibition of interleukin-1 beta converting enzyme family proteasese reduces ischemic and excitotoxic neuronal damage[J]. Proc Natl Acad Sci USA,1997,94(5):2007-2012.
[131]Stroemer R P,Rothwell N T. Exacerbation of ischemlic brain damage by localized striatal injection of intrleukin-1 β in the rat. J Cereb Blood Flow[J].Metab,1998,18(8):833-839.
[132]刘清和,张兆辉,余绍祖.抗TNF-α单克隆抗体对局灶性脑缺血作用的初步研究[J].中国神经精神疾病杂志,1999,25(3)：169-170.
[133]Emsley H C, Ynelt P J Inflammation and infection in clinical stroke. J Cereb Blood Flow[J].Metab,2002,22(12):1399-1419.
[134]李文,包仕尧.碱性成纤维细胞生长因子治疗脑梗死研究进展[J].国外医学脑血管疾病分册,1999,7(4)：227.
[135]Shinn Z L,Holler B J, KaPlan P, et al. Osteogenic protein-1 Protects against cerebral in farction induced by MCA ligation in adult rats[J]. Stroke,1999,30(1):126-133.
[136]Poon WS, Lu Gang KS, et al. Migration of bone marow stem cellsin ischemic brain [J].Acta Neurochir Suppl,2006,99:123-124.
[137]Ding S, Messam CA, Li P, et al.Murine brain progenitor cells have the ability to differentiate into functional neurons and integrate into the CNS[J].Cell Transplant,2006,15(8):699-710.
[138]Me Leod M, Hong M, Sen A,et al.Transplantation Of bioreactor-produced neural stem cells into the rodent brain[J]. Cell Transplant,2006,15(8):689-697.
[139]Li Y, Chen J, Chen XG, et al. Human marow stromal cell therapy for stroke in rat:neurotrophins and functional recovery[J].Neurology,2002,59(4):514-523.
[140]Yadav JS, Wholey M H, Kuntz RE, et al. Protected carotid2artery stenting versus endarterectomy in high-risk patients[J].N Engl J Med,2004,351:1493-1501.
[141]CAVATAS investigators. Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Artery TransluminalAngioplasty Study (CAVATAS):a randomized trial[J]. Lancet,2001, 357:1729-1737.
[142]Hobson RW. CREST(Caro tid Revascu larization Endarterectomy versus Stent Trial):background, design, and current status[J]. Semin Vase Surg,2000, 13:139-143.
[143]Mas JL, Chatellier G, Beyssen B. Endarterectomy versus stenting in Patients with Symptomatic Severe Carotid Stenosis[J]. N Engl J Med,2007,355: 1660-1671.
[144]凌锋.缺血性脑血管病介入治疗现状和存在的问题[J].实用医院临床杂志,2008,5(2)：3-5.
[145]Cruz-Flores S, Diamond AL. Angiop lasty for in tracranial artery stenosis[J]. Cochrane Database of Systematic Reviews,2006,3:1500-1505.
[146]Adarns H, Adams R, Del Zoppo G, et al. Guidelines for the early management of patients with ischemic stroke:2005 guidelines update a scientific statemen from the stroke council of the american heart association/american stroke association[J]. Stroke,2005,36(4):916-923.
[147]Smith WS, Sung G, Starkman S, et al. Safety and efficacy of embolevtomy in acute ischemic stroke[J]. Stroke,2005,36:1432-1440.
[148]Smith WS. Safety of mechanical, thrombectomy and intravenous tissue plasminogen activator in acute ischemic stroke. Results of the multi mechanical embolus removal in cerebral ischemia(MERCI)trial[J].AJNR,2006,27:1177-1182.
[149]1 Rha JH, Saver JL. Recanalization as a surrogate outcome measure in thrombolitic clinical trials:a meta-analysis[J]. Stroke,2003,34:317.
[150]Gonzdlez A, Mayol A, Eva Martinez E, et al. Mechanical thrombectomy with snarei in patients with acute ischemic stroke [J]. Neuroradiology,2007,49:365-372.
[151]Chris Wei hl, R Loch Macdonald, et al. Gene therapy for cerebrovascular disease[J]. Neurosurgery,1999,44(2):239-246
[152]杨莉,高颖昌,赵志刚.鼻腔给药的研究进展[J].中国药学杂志,2006,22(11)：1685-1688.
[153]陆彬.药物新剂型与新技术[M].2版.北京：人民卫生出版社,2005.
[154]王东兴,高永良.鼻腔给药新剂型研究进展[J].中国新药杂志,2002,11(8)：589-592.
[155]张翔,郝伟,宁斌,等.中药鼻腔给药制剂的研究进展[J].山东大学耳鼻喉眼学报,2005,19(12)：412-413.
[156]金方,谢保源,施丽西.用于全身治疗的鼻腔给药系统[J].中国医药工业杂志,1998,29(3)：137-141.
[157]石森林,徐莲英.脑部疾病的鼻腔给药研究[J].中药新药与临床药理,2004,15(3)：145-148.
[158]程巧鸳,朱文静.鼻腔给药的生物利用度研究进展[J].国外医学：药学分册,2004,37(3)：168-172.
[159]周金英.中药药理学[M].上海：上海科学技术出版社,1985,190.
[160]许莲英.冰片的药理研究[J].中成药研究,1986,(3)：1.
[161]陈铁峰.冰片促四甲基吡嗪吸收[J].中国药理学报,1990,11(1)：42.
[162]汪春,陈宏珪,雷娓娓.脑醒喷鼻剂治疗急性缺血性中风的实验研究[J].广州中医药大学学报,1999,16(2)：119-122.
[163]刘煜德,吴伟,陈宏珪.脑醒冲剂对大鼠脑组织缺血再灌注保护作用的实验研究[J].新中医,2002,34(1)：72-74.
[164]吴伟,陈宏珪,刘煜德.脑醒冲剂对人鼠全脑缺血及再灌注皮层脑电位的影响[J].中药新药与临床药理,2002,13(6)：379-380.
[165]李荣,吴伟,陈宏硅,等.脑醒喷鼻剂对人鼠脑缺血再灌注损伤脑组织超微结构的影响[J].中药新药与临床药理,2003,14(1)：10-13.
[166]孙寒静,黄天来,宓穗卿,等.芎冰喷雾剂脑内药物动力学研究[J].中药新药与临床药理,2003,14(3)：177-179.
[167]刘煜德,孙寒静,李荣,等.冰片对川芎嗪经鼻腔吸收入脑的影响[J].中国中药杂志,2008,33(3)：259-261.
[168]汪春,陈宏珪,吴伟.脑醒喷鼻剂治疗急性缺血性中风的临床观察[J].中药新药与临床药理,2000,11(6)：333-335.
[169]杨开清,陈宏硅,黄衍寿.脑醒冲剂治疗急性缺血性中风的临床研究[J].广州中医药大学学报,2001,18(3)：224-225.
[170]杨开清,李荣,陈宏硅.脑醒喷鼻剂治疗急性缺血性中风66例[J].广州中医药大学学报,2003,20(1)：28-30.
[171]李荣,吴伟,刘煜德,等.脑醒喷鼻剂对脑梗塞患者血管内皮功能及血液流变学的影响[J].辽宁中医杂志,2005,32(9)：877-888.
[172]杨开清,李荣,陈宏珪.脑醒喷鼻剂对缺血性中风患者血管内皮细胞功能的影响[J].中药新药与临床药理,2005,16(2)：139-141.
[173]徐慧聪.芎冰喷雾剂对椎—基底动脉供血不足的即时疗效[J].中西医结合心脑血管病杂志,2006,4(5)：388-390.
[174]洪创雄,明康文.芎冰喷雾剂合参麦注射液治疗椎基底动脉缺血性眩晕临床观察[J].实用医学杂志,2003,19(8)：932-933.
[175]徐辉碧,谢长生.纳米技术在中药研究中的应用[J].中国药科大学学报,2001,32(8)：161-165.
[176]刘喆,赖新生.大脑中动脉闭阻脑缺血模型大鼠的建立与评价[J].中国行为医学科学,2005,14(10)：877.
[177]Longa E Z, Weinstein P R, Carlson S,et al.Reversible middle cerebral artery occlusion without craniectomy in rats [J].Stroke,1989,20(1):84-91.
[178]徐立新,袁芳.改良的大鼠脑局部缺血模型[J].中国康复理论与实践,2005,11(1)：23-24.
[179]Bederson J B, Pitts LH, Tsuji M, et al.Rat middle cerebral artery occlusion :evaluation of the model and development of a neurologic examination [J]. Stroke,1986,17:472-476.
[180]Petullo D, Masonic K, Lincoln C, et al. Model development and behavioral assessment of foeal cerebral ischemia in rats[J]. Life Sciences,1999,64:1099-1108.
[181]张荣嫒,张宏伟,尚爱加.大鼠大脑中动脉缺血再灌注模型制备及行为学评价标准的改进[J].军医进修学院学报,2008,29(5)：422-423.
[182]Hartfield RH, Mendelow AD, Perry RH, et al. Triphenyltetrazoliurn chloride (TTC)as a marker for ischemic changes in rat brain following permanent middle cerebral artery occlusion[J].Neuropathol Appl Neurobiol,1991,17:61-67.
[183]Naddas M M, Sandriter TK. Microscopic identification of early myocardial infarcts by dehyaroge alterations[J]. Am J Pathol,1963,42:379-405.
[184]周剑,高培毅,李小光.实验性大鼠脑血肿周围脑组织血流变化的CT灌注成像研究[J]..中华放射学杂志,2005,39(5)：538-543.
[185]刘鹏斌,常丹,宋正川.氯胺酮麻醉对大鼠局灶性脑缺血模型病理结局的影响[J].第四军医大学学报,2006,27(3)：212-214.
[186]Eamshaw WC, Martins LM, Kaufinann SH. Mammalian caspase:structure, activation,suhstrates, and functions during apoptosi[J]s. Annu Rev Biochem, 1999,68:382-424.
[187]Ferrer I,Friguls B, DalfoE, et al. Caspase-dependent an caspase-independent signaling of apoptosis in the penumbr following middle cerebml artery occlusion in the adult rat[J].Neuropathol Appl Neurobiol,2003, 29(5):472-481.
[188]Solarogu I, Tsubokawa T, Cahill J, et al. Anti-apoptotic effect of granulocyte colony stimulating factor after focal cerebral ischemia in the rat[J].Neuroscience,2006,143(4):965-74.
[189]Howard Y. Proteases for cell suicide:functions and regulation of caspases [J].Mierobiol Mol Biol Rev,2000,64(4):821-846.
[190]刘天会,陈瑞,杜艳玲.小鼠短暂前脑缺血海马中半胱天冬酶-3酶原表达的变化[J].中国生物化学与分子生物学报,2006,2(1)：55-58.
[191]Reed J C.Apoptosis based thempies[J]. Nat Rev Drug Discov.2002,1(5):111-121.
[192]Papadopoulos MC, Krishna S, VerkmanAS. Aquaporin water channels and brain edema [J].Mt SinaiJMed,2002,694:242-248.
[193]Aoki K, Uchihara T, Tsuchiya K, et al. Enhanced expression of aquaporin-4 in human brain with infarction[J]. Acra Neuropathol,2003,106(2):121-124.
[194]Manley GT, FujimuraM, Ma T, et al. Aquaporin-4 deletion in mice reduces brain edema after acute water introxication and ischemic stroke [J]. NatMed, 2000,6(2):159-163.
[195]Amberger A, Weiss H, Hailer T, et al.A subpopulatio of mitochondria prevents cytosolic calcium overload in endothelial cells after cold ischemia/ reperfusion[J]. Transplantation,2001,71(12):1821-1827.
[196]张拥波,董为伟,王得新.caspase-3抑制药和钙拮抗药联合应用对氧糖剥夺性神经元缺血损害的保护作用[J].中国现代神经疾病杂志,2007,7(1)：57-60.
[197]Takadera T, Ohyashiki T.Apoptotic cell death and caspase-3(CPP32) activation induced by calcium ionophore at low concentrations and their prevention by nerve growth factor in PC12 cells[J].Eur J Biochem,1997,249: 8-12.
[198]李燕华,孙善全,李吕力.低渗状态下星形胶质细胞AQP 4mRNA的表达和Ca2+浓度的关系[J].中风与神经疾病杂志,2005,22(4)：292-296.
[199]滕伟禹,田力,刘宏丽,等.水蛭素、尼膜同对大鼠实验性脑出血后AQP4mRNA表达及脑水肿的作用研究[J].中国现代医学杂志,2006,16(9)：1290-1293.
[200]李露斯,刘之荣,肖桃元,等.大鼠慢性脑血流灌注不足脑的病理组织学和超微结构变化[J].第三军医大学学报,1999,21：1042-1045.
[201]John S, Strven P.Immunophilins mediate the neuroprotective effects of FK506 in focal cerebral ischemia[J].Nature,1994,371:326-339.
[202]DeGraba TJ. The role of inflammation after acute stroke:utility of pursuing anti-adhesion molecule therapy[J]. Neurology,1998,51:62-68.
[203]Malik, ST. The activity of TNF in experiment cancer models In Beutler Red Tumor Necrosis Factors[J]. New York:Raven Press,1991,407:23
[204]Zaremba J, Skrobanski P, Losy J. Tumour necrosis factor-α is increased in the cerebrospinal fluid and serum of ischemic stroke patients and correlates with the volume of evolving brain infarct[J]. Biomed Pharmacother,2001,55:258-263.
[205]Vila N, Castillo J, Davalos A, et al. Proinflammatory cytokines and early neurological worsening in ischemic stroke[J]. Stroke,2000,31:2325-2329.
[206]Barone FC, Arvin R, White RF, et al. Tumor necrosis factor-α. A mediator of focal ischemic brain injury[J].Stroke,1997,28:1233-1244.
[207]Fan L, Young PR, Barone FC,et al. Experimental brain injury induces expression of interleukin-1 beta messenger RNA in the rat brain[J].Mol Brain Res,1995,30(1):125-130.
[208]Rothwell NJ. Cytokines-killers in the brain?[J] J Physiology,1999,514(1) :3-17.
[209]中华医学会神经病学分会.脑卒中患者临床神经功能缺损程度评分标准[J].中华神经科杂志,1996,29：381-383.
[210]王拥军,颜振瀛,王新,等.脑卒中患者神经功能缺损程度评分标准的修订以及信度和效度研究[J].世界医学杂志,2002,6(8)：16-20.
© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号 地址：北京市海淀区学院路29号 邮编：100083 电话：办公室：(+86 10)66554848；文献借阅、咨询服务、科技查新：66554700 |